Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Hagipantelli
Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Related publications
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Prognostic and Predictive Factors in Early-Stage Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Test of a Weight Gain Prevention Intervention in Stage II and III Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Local Radiotherapy Alone Following Neoadjuvant Chemotherapy and Surgery in Combined Clinical Stage II and III Breast Cancer
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
Patients With Breast Cancer Who Are Treated With Chemotherapy Risk Long-Term Nerve Damage
Cancer
Cancer Research
Oncology
Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer
Journal of Breast Disease
Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Cancer Management and Research
Oncology
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
